Newland Pharmaceutical Co., Ltd. announced that at its Annual General Meeting held on 23 April 2024, approved election of Liu Hongmin as non-independent director; and Ke Yu and Jia Faliang as independent directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 CNY | -0.14% |
|
+2.50% | -6.22% |
1st Jan change | Capi. | |
---|---|---|
-6.22% | 538M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 301277 Stock
- News Newland Pharmaceutical Co., Ltd.
- Newland Pharmaceutical Co., Ltd. Announces Board Elections